Clinical Trial Update: Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates the efficacy and safety of cetuximab combined with cisplatin and gemcitabine as first-line therapy for advanced non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Grupo Portugues de Estudo do Cancro do Pulmao | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN